K071446 is an FDA 510(k) clearance for the ELECTRODE ARRAY CAP. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.
Submitted by Electrode Arrays (El Paso, US). The FDA issued a Cleared decision on July 2, 2008 after a review of 405 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.
View all Electrode Arrays devices